MEMORIA 2024 - Área 6. Inmunología, Microbiología y Enfermedades Infecciosas

Área 6. Inmunología, Microbiología y Enfermedades Infecciosas

OBJETIVOS CIENTÍFICOS VINCULADOS AL PLAN ESTRATÉGICO

Generar conocimiento científico de excelencia: nuestros números son muy parecidos a los del año anterior. 96 publicaciones y un liderazgo del 61%.
Captación de talento científico: se han conseguido 6 ayudas de recursos humanos competitivas. Se ha conseguido mantener el personal de apoyo captado el año anterior.
Dinamizar la captación de recursos: la captación de recursos ha sido parecida a 2023 en número y algo inferior en cuantía. Los ingresos por investigación clínica se han reducido levemente.

9 Grupos de Investigación

INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA (CONSOLIDADO)
INMUNIDAD, INFLAMACIÓN Y CÁNCER (CONSOLIDADO)
TRASPLANTE HEMATOPOYÉTICO / TERAPIA CELULAR (CONSOLIDADO)
INMUNIDAD INNATA EN LA SALUD Y LA ENFERMEDAD (EMERGENTE)
PATOLOGÍA INFECCIOSA, MICROBIOLOGÍA CLÍNICA Y MEDICINA TROPICAL (EMERGENTE)
ONCOLOGÍA CLÍNICA Y TRASLACIONAL (CLÍNICO ASOCIADO)
AUTOFAGIA, RESPUESTA INMUNE Y TOLERANCIA EN PROCESOS PATOLÓGICOS (EMERGENTE)
BIOINGENIERÍA TISULAR Y MEDICINA REGENERATIVA (EMERGENTE)
FARMACIA CLÍNICA Y TERAPÉUTICA (CLÍNICO ASOCIADO)

INDICADORES GENERALES

Nº Publicaciones

565.7

Impacto Total

5.89

Impacto Medio

Tipo	Nº Pubs	FI total	FI Medio
Originales	82 (85.42%)	503.8	6.14
Revisiones	14 (14.58%)	61.9	4.42

71.88

Q1%

23.96

D1%

FI >= 15

Tipo	Nº Q1	Nº D1	Nº FI >= 15
Originales	57	22	3
Revisiones	12	1	0

INDICADORES DE LIDERAZGO

58 (60.0%)

Nº Publicaciones

222.6

Impacto Total

3.84

Impacto Medio

	Nº Pubs	FI total	FI Medio
Mujer	36 (62.07%)	134.2	3.73
Hombre	22 (37.93%)	88.4	4.02

75.86

Q1%

22.41

D1%

FI >= 15

	Nº Q1	Nº D1	Nº FI >= 15
Mujer	28	7	0
Hombre	16	6	0

OTROS INDICADORES

21.8

HCP10% (2020-2024)

41.24

HCP10 Liderado% (2020-2024)

22.68

HCP10 Lid. Mujeres% (2020-2024)

1.99

Crown (2020-2024)

72.92

Open Access%

23.96

Col. International%

* Se muestran las 5 especies, los 10 genes y las 20 enfermedades más nombradas. Los valores están normalizados logarítmicamente en base al número de publicaciones.

INDICADORES EVOLUTIVOS

DESTACADAS

Bueno C*, Garcia-Bernal D, Martinez S, ..., Moraleda JM. The nuclei of human adult stem cells can move within the cell and generate cellular protrusions to contact other cells. Stem Cell Research & Therapy, 2024, 15, 32, PMID: 38321563, FI: 7.3

Arroyo AB*, Tyrkalska SD, Bastida-Martinez E, ..., Garcia-Moreno D*, ..., Mulero V*. Peds1 deficiency in zebrafish results in myeloid cell apoptosis and exacerbated inflammation. Cell Death Discovery, 2024, 10, 388, PMID: 39209813, FI: 7.0

Lopez Soto A, Velasco Martinez M, Ferrandez Martinez M, ..., Marin Sanchez P*. Prenatal ambiguous/atypical genitalia: why are we still missing it and how can we improve diagnosis? Ultrasound in Obstetrics & Gynecology, 2024, 63, 581-585, PMID: 37773980, FI: 6.3

Osorio R, Rodriguez-Lozano FJ, Toledano M et al. Mitigating lipopolysaccharide-induced impairment in human dental pulp stem cells with tideglusib-doped nanoparticles: Enhancing osteogenic differentiation and mineralization. Dental Materials, 2024, 40, 1591-1601, PMID: 39068091, FI: 6.3

Lopez-Garcia S, Aznar-Cervantes SD, Pagan A, ..., Rodriguez-Lozano FJ* et al. 3D Graphene/silk fibroin scaffolds enhance dental pulp stem cell osteo/odontogenic differentiation. Dental Materials, 2024, 40, 431-440, PMID: 38114344, FI: 6.3

LISTADO COMPLETO

Oaknin A, Gladieff L, Martinez-Garcia J et al. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. Lancet, 2024, 403, 31-43, PMID: 38048793, FI: 88.5

Bardia A, Hu X, Dent R et al. COLABORADORES: Streich G, Cundom J, Constanzo MV, ..., Alonso Romero JL et al. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer. New England Journal of Medicine, 2024, 391, 2110-2122, PMID: 39282896, FI: 78.5

Puig N, Agullo C, Contreras T, ..., Moraleda JM et al. Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma. Blood, 2024, 144, 2432-2438, PMID: 39293025, FI: 23.1

Oliver-Caldes A, Espanol-Rego M, Zabaleta A, ..., Cabanas V et al. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clinical Cancer Research, 2024, 30, 2085-2096, PMID: 38466644, FI: 10.2

Peressini M, Garcia-Campelo R, Massuti B, ..., Ros S et al. Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer. Clinical Cancer Research, 2024, 30, 3036-3049, PMID: 38630755, FI: 10.2

Llombart-Cussac A, Perez-Garcia JM, Ruiz Borrego M, ..., Alonso-Romero JL et al. Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial. Eclinicalmedicine, 2024, 71, 102520, PMID: 38638399, FI: 10.0

Royo-Villanova M, Minambres E, Sanchez JM, ..., de Paco Tudela G et al. Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: Results of a prospective clinical study. American Journal of Transplantation, 2024, 24, 213-221, PMID: 37739346, FI: 8.2

Lakhwani S, Rosinol L, Puig N, ..., De Arriba F et al. Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection. Haematologica, 2024, 109, 1909-1917, PMID: 38031761, FI: 7.9

Chalkias A, Huang Y, Ismail A, ..., Bernal-Morell E et al. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study. Critical Care Medicine, 2024, 52, 930-941, PMID: 38391282, FI: 6.0

Gil-Chinchilla JI, Bueno C, Martinez CM, ..., Moraleda JM*, Garcia-Bernal D*. Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics. Frontiers in Immunology, 2024, 15, 1385691, PMID: 38605955, FI: 5.9

Alonso Garcia L, Bueno Sanchez D, Fernandez Navarro JM, ..., Blanquer Blanquer M et al. Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience. Frontiers in Immunology, 2024, 15, 1307932, PMID: 38370416, FI: 5.9

Mo CC, Richardson E, Calabretta E, ..., Moraleda JM et al. Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide. Blood Reviews, 2024, 66, 101218, PMID: 38852017, FI: 5.7

Puig-Herreros C, Sanz JL, Garcia-Bernal D et al. Comparative Cytotoxicity of Menthol and Eucalyptol: An In Vitro Study on Human Gingival Fibroblasts. Pharmaceutics, 2024, 16, PMID: 38675182, FI: 5.5

Gimenez-Bastida JA, Avila-Galvez MA, Martinez-Lopez A et al. (R,S)-Equol 7-beta-D-glucuronide, but not other circulating isoflavone metabolites, modulates migration and tubulogenesis in human aortic endothelial cells targeting the VEGF pathway. Food & Function, 2024, 15, 7387-7399, PMID: 38078511, FI: 5.4

Singh G., Heena, Gill B.S. et al. Naked eye Fe(III) recognition and anticancer efficacy evaluation via diazenyl-propargyl appended imine functionalized moiety Journal of Molecular Liquids, 2024, 412, PMID: null, FI: 5.2

Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, ..., Minguela A. Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD. Cells, 2024, 13, PMID: 39768157, FI: 5.2

Ruiz-Lorente I*, Gimeno L, Lopez-Abad A, ..., Minguela A*. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells, 2024, 13, PMID: 39682686, FI: 5.2

Aghdam MA, Pagan A, Garcia-Estan J*, Atucha NM*. Evaluation of the Effects of Mulberry Leaf Extracts Morus alba L. on Cardiovascular, Renal, and Platelet Function in Experimental Arterial Hypertension. Nutrients, 2024, 17, PMID: 39796483, FI: 5.0

Valentin MO, Crespo M, Fernandez C, Muro M et al. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch. Transplantation, 2024, 108, 787-801, PMID: 37867239, FI: 5.0

Garcia-Izquierdo L, Marin-Sanchez P, Garcia-Penarrubia P, Martinez-Esparza M. New Potential Pharmacological Options for Endometriosis Associated Pain. International Journal of Molecular Sciences, 2024, 25, PMID: 39000175, FI: 4.9

Salinas MD, Rodriguez P, Rubio G, Valdor R*. Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis. International Journal of Molecular Sciences, 2024, 26, PMID: 39796053, FI: 4.9

Sanchez-Villalobos M, Campos Banos E, Martinez-Balsalobre E, ..., Perez-Oliva AB*. Whole Blood Transcriptome Analysis in Congenital Anemia Patients. International Journal of Molecular Sciences, 2024, 25, PMID: 39519257, FI: 4.9

Gramignoli R, Hofmann N, Agudo-Barriuso M, ..., Nicolas FJ* et al. Expert Revision of Key Elements for Clinical-Grade Production and Qualification of Perinatal Derivatives. Stem Cells Translational Medicine, 2024, 13, 14-29, PMID: 38071447, FI: 4.9

Alvarez-Santacruz C, Tyrkalska SD, Candel S*. The Microbiota in Long COVID. International Journal of Molecular Sciences, 2024, 25, PMID: 38279329, FI: 4.9

Mastrogiovanni M, Martinez-Navarro FJ*, Bowman TV, Cayuela ML. Inflammation in Development and Aging: Insights from the Zebrafish Model. International Journal of Molecular Sciences, 2024, 25, PMID: 38396822, FI: 4.9

Stelling-Férez J., Puente-Cuadrado J.M., Álvarez-Yepes V., ..., Nicolás F.J.*. Refrigerated amniotic membrane maintains its therapeutic qualities for 48 hours Frontiers in Bioengineering and Biotechnology, 2024, 12, PMID: null, FI: 4.8

Gil-Chinchilla JI, Zapata AG, Moraleda JM, Garcia-Bernal D*. Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects. Biomolecules, 2024, 14, PMID: 39062449, FI: 4.8

Gomez I, Egui A, Palacios G, Carrilero B et al. The expression of immune response genes in patients with chronic Chagas disease is shifted toward the levels observed in healthy subjects as a result of treatment with Benznidazole. Frontiers in Cellular and Infection Microbiology, 2024, 14, 1439714, PMID: 39119291, FI: 4.8

Tyrkalska SD, Perez-Sanz F, Franco-Martinez L, ..., Candel S*. Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID. Frontiers in Cellular and Infection Microbiology, 2024, 14, 1396263, PMID: 38881733, FI: 4.8

Stelling-Ferez J, Puente-Cuadrado JM, Alvarez-Yepes V, ..., Nicolas FJ. Refrigerated amniotic membrane maintains its therapeutic qualities for 48 hours. Frontiers in Bioengineering and Biotechnology, 2024, 12, 1455397, PMID: 39569163, FI: 4.8

Simoes MP, Hodcroft EB, Simmonds P, ..., Moreno-Docon A et al. Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study. Journal of Infectious Diseases, 2024, 230, e917-e928, PMID: 38547499, FI: 4.5

Domínguez-Maqueda M., Espinosa-Ruíz C., Esteban M.Á. et al. An ex vivo Approach in European Seabass Leucocytes Supports the in vitro Regulation by Postbiotics of Aip56 Gene Expression of Photobacterium damselae subsp. piscicida Probiotics and Antimicrobial Proteins, 2024, doi: 10.1007/s12602-024-10255-x, PMID: null, FI: 4.4

Toquet M., Bataller E., Toledo-Perona R. et al. In Vitro Interaction between Mycoplasma agalactiae and Small Ruminants’ Endogenous Bacterial Strains of Enterococcus spp. and Coagulase-Negative Staphylococcus Microorganisms, 2024, 12, PMID: null, FI: 4.2

Suarez-Martinez C, Santaella-Pascual M*, Yague-Guirao G, ..., Martinez-Gracia C*. The Early Appearance of Asthma and Its Relationship with Gut Microbiota: A Narrative Review. Microorganisms, 2024, 12, PMID: 39065238, FI: 4.2

Valdor R*, Martinez-Vicente M. The Role of Chaperone-Mediated Autophagy in Tissue Homeostasis and Disease Pathogenesis. Biomedicines, 2024, 12, PMID: 38397859, FI: 3.9

Albaladejo-Riad N, El Qendouci M, Cuesta A et al. Ability of short-chain fatty acids to reduce inflammation and attract leucocytes to the inflamed skin of gilthead seabream (Sparus aurata L.). Scientific Reports, 2024, 14, 31404, PMID: 39732927, FI: 3.9

Campos-Sanchez JC, Esteban MA et al. Effects of dietary astaxanthin on immune status and lipid metabolism in gilthead seabream (Sparus aurata). Fish & Shellfish Immunology, 2024, 151, 109731, PMID: 38944253, FI: 3.9

Campos-Sanchez JC, Guardiola FA, Esteban MA et al. Serum proteinogram of gilthead seabream (Sparus aurata) and European sea bass (Dicentrarchus labrax) as a new useful approach for detecting loss of haemostasis. Fish & Shellfish Immunology, 2024, 151, 109699, PMID: 38876410, FI: 3.9

Ortiz M, Esteban MA et al. Biology and functions of fish thrombocytes: A review. Fish & Shellfish Immunology, 2024, 148, 109509, PMID: 38493985, FI: 3.9

Campos-Sanchez JC, Guardiola FA, Esteban MA et al. In vitro immune-depression and anti-inflammatory activities of cantharidin on gilthead seabream (Sparus aurata) leucocytes activated by lambda-carrageenan. Fish & Shellfish Immunology, 2024, 148, 109470, PMID: 38442766, FI: 3.9

De Alba G., Céspedes L., Campos-Sánchez J.C., ..., López-Olmeda J.F.*. Time of day-dependent effects of heat treatment on thermal tolerance and sex differentiation in Nile tilapia (Oreochromis niloticus) Aquaculture, 2024, 581, PMID: null, FI: 3.9

Esteban MA et al. A review of soluble factors and receptors involved in fish skin immunity: The tip of the iceberg. Fish & Shellfish Immunology, 2024, 145, 109311, PMID: 38128682, FI: 3.9

Pecci-Lloret M.P., Gea-Alcocer S., Murcia-Flores L., Rodríguez-Lozano F.J. et al. Use of Nanoparticles in Regenerative Dentistry: A Systematic Review Biomimetics, 2024, 9, PMID: null, FI: 3.9

Rodriguez-Valiente M*, Garcia-Hernandez AM, Fuente-Mora C, ..., Nicolas FJ. Management of Foot Ulcers and Chronic Wounds with Amniotic Membrane in Comorbid Patients: A Successful Experience. Biomedicines, 2024, 12, PMID: 39457692, FI: 3.9

Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, ..., Minguela A. Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases. Biomedicines, 2024, 12, PMID: 39595006, FI: 3.9

Beltran A*, Sanchez-Villalobos M, Salido E, ..., Moraleda JM. Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects. Biomedicines, 2024, 12, PMID: 39062184, FI: 3.9

Osete JM, Garcia-Candel F, Fernandez-Gomez FJ, ..., Iyu D. TRAP-Induced Platelet Reactivity Is Inhibited by Omega-3 Fatty Acid-Derived Prostaglandin E3 (PGE3). Biomedicines, 2024, 12, PMID: 39767761, FI: 3.9

Legaz I*, Jimenez-Coll V, Gonzalez-Lopez R, ..., Muro M*. MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. Biomedicines, 2024, 12, PMID: 38255221, FI: 3.9

Collados-Ros A, Muro M, Legaz I*. Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review. Biomedicines, 2024, 12, PMID: 38255313, FI: 3.9

Legaz I*, Navarro-Noguera E, Collados-Ros A, ..., Muro M*. Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis. Biomedicines, 2024, 12, PMID: 38397937, FI: 3.9

Wang R, Underwood M, Llibre JM, Bernal Morell E et al. Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study. Open Forum Infectious Diseases, 2024, 11, ofad626, PMID: 38213637, FI: 3.8

Ortiz de Landazuri I, Oliver-Caldes A, Espanol-Rego M, ..., Moraleda JM et al. Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells. British Journal of Haematology, 2024, 205, 1346-1355, PMID: 38894496, FI: 3.8

Hidalgo-Gomez G, Minguela A, Tazon-Vega B et al. Clonal heterogeneity and genomic evolution in intrachromosomal amplification of chromosome 21: A case report. British Journal of Haematology, 2024, 204, 2512-2515, PMID: 38665061, FI: 3.8

Lopez-Garcia S, Pecci-Lloret MR, Pecci-Lloret MP, Garcia-Bernal D et al. Influence of the post-processing protocol on a biocompatible 3D-printed resin. Journal of Prosthodontics-Implant Esthetic and Reconstructive Dentistry, 2024, 10.1111/jopr.13980 [doi], PMID: 39506359, FI: 3.6

Botella C, Galian JA, Jimenez-Coll V, ..., Muro M*. Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center. Life-Basel, 2024, 14, PMID: 39598289, FI: 3.4

Corrales J.C., Sánchez A., Hernández X., Amores-Iniesta J. et al. A Set of Multiresistant Isolates of Mycoplasma bovis Subtype ST-1 with a Variable Susceptibility to Quinolones Are Also Circulating in Spain Pathogens, 2024, 13, PMID: null, FI: 3.3

Jiménez-Monreal A.M., Guardiola F.A., Antonia Murcia M. et al. Effect of dietary fenugreek seeds on the antioxidant status of gilthead seabream (Sparus aurata L.) Journal of Food Science and Technology-Mysore, 2024, doi: 10.1007/s13197-024-06096-9, PMID: null, FI: 3.3

Pons-Fuster E*, Lozano-Caballero O, Martin-Balbuena S et al. Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. International Journal of Clinical Pharmacy, 2024, 46, 1317-1326, PMID: 38990457, FI: 3.2

Singh G., Devi S., Singh A. et al. 1,2,3-Triazole appended Schiff base functionalized silanes: A colorimetric sensor of Al (III) and a potent inhibitor of butyrylcholinesterase in Alzheimer's diseases via molecular docking Inorganica Chimica Acta, 2024, 572, PMID: null, FI: 3.2

Braik A, Serna-Duque JA, Nefzi A et al. Potential therapeutic use of dermaseptin S4 from the frog Phyllomedusa sauvagii and its derivatives against bacterial pathogens in fish. Journal of Applied Microbiology, 2024, 135, PMID: 39187398, FI: 3.2

Mora A, Garcia-Bernal D, Rodriguez-Lozano FJ et al. Biocompatibility, bioactivity and immunomodulatory properties of three calcium silicate-based sealers: an in vitro study on hPDLSCs. Clinical Oral Investigations, 2024, 28, 416, PMID: 38969964, FI: 3.1

Ramirez de Arellano E, Saavedra-Lozano J, Villalon P, ..., Yague G et al. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak. Msphere, 2024, 9, e0072923, PMID: 38440985, FI: 3.1

Bahi A., Bhaskaracharya R., Esteban M.A. et al. Dietary administration impact of olive pulp on growth performance, metabolic profile, immune status, and antioxidant potential of gilthead seabream (Sparus aurata L.) Frontiers in Sustainable Food Systems, 2024, 8, PMID: null, FI: 3.1

Sanz JL, Lopez-Garcia S, Garcia-Bernal D, Rodriguez-Lozano FJ* et al. Comparative bioactivity and immunomodulatory potential of the new Bioroot Flow and AH Plus Bioceramic sealer: An in vitro study on hPDLSCs. Clinical Oral Investigations, 2024, 28, 195, PMID: 38441709, FI: 3.1

Campos-Sánchez J.C., Guardiola F.A., Esteban M.Á. et al. In vitro effects of a natural marine algae polysaccharide (λ-carrageenan) on seabream erythrocytes, tumour cell lines and marine bacterial pathogens Journal of Applied Phycology, 2024, 36, PMID: null, FI: 3.0

Toledo-Perona R., Contreras A., Gomis J. et al. Controlling Coxiella burnetii in naturally infected sheep, goats and cows, and public health implications: a scoping review Frontiers in Veterinary Science, 2024, 11, PMID: null, FI: 2.9

Pecci-Lloret M.P., Linares-Pérez C., Pecci-Lloret M.R., Rodríguez-Lozano F.J. et al. Oral Manifestations in Pregnant Women: A Systematic Review Journal of Clinical Medicine, 2024, 13, PMID: null, FI: 2.9

Corbalan-Velez R, Ruiz-Macia JA, Lopez-Martinez D, Moreno Docon A et al. Pigmented acuminated condylomas seborrhoeic keratosis-like: a new entity? Sexually Transmitted Infections, 2024, 100, 524-527, PMID: 38964839, FI: 2.9

Elen S, Bjorkman P, Zazzi M, ..., Bernal E et al. Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression. Hiv Medicine, 2024, 25, 107-116, PMID: 37721192, FI: 2.8

Piñera-Moreno R., Reyes-López F.E., Goldstein M. et al. Transcriptional Evaluation of Neuropeptides, Hormones, and Tissue Repair Modulators in the Skin of Gilthead Sea Bream (Sparus aurata L.) Subjected to Mechanical Damage Animals, 2024, 14, PMID: null, FI: 2.7

Li X, Zhang Y, Zhu C, ..., Martinez DAS et al. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer. Bmc Womens Health, 2024, 24, 38, PMID: 38218823, FI: 2.7

Lopez-Garcia S, Perez-Guzman N, Rodriguez-Lozano FJ et al. Biological Effects of New Chemical-Mechanical Caries Removal Products on Human Dental Pulp Stem Cells. Caries Research, 2024, 58, 612-624, PMID: 38959874, FI: 2.6

Ferez-Puche M, Serna-Duque JA, Cuesta A et al. Identification of a Novel beta-Defensin Gene in Gilthead Seabream (Sparus aurata). , 2024, 26, 1219-1230, PMID: 39259315, FI: 2.6

Campos-Sanchez JC, Serna-Duque JA, Alburquerque C et al. Participation of Hepcidins in the Inflammatory Response Triggered by lambda-Carrageenin in Gilthead Seabream (Sparus aurata). , 2024, 26, 261-275, PMID: 38353762, FI: 2.6

Dominguez-Maqueda M, Garcia-Marquez J, Tapia-Paniagua ST et al. Evaluation of the Differential Postbiotic Potential of Shewanella putrefaciens Pdp11 Cultured in Several Growing Conditions. , 2024, 26, 1-18, PMID: 38153608, FI: 2.6

Lopez-Garcia S, Sanz JL, Murcia L, ..., Rodriguez-Lozano FJ* et al. Assessment of the anti-inflammatory and biological properties of Bioroot Flow: A novel bioceramic sealer. Tissue & Cell, 2024, 88, 102391, PMID: 38657320, FI: 2.5

Ramos Elbal E*, Fuster JL, Campillo JA, ..., Minguela A*. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clinical & Translational Oncology, 2024, 26, 278-287, PMID: 37368200, FI: 2.5

Lopez-Garcia S, Sanz JL, Onate-Sanchez RE, ..., Garcia-Bernal D et al. In vitro biocompatibility of ammonia-free silver fluoride products on human dental pulp stem cells. Tissue & Cell, 2024, 86, 102283, PMID: 38113650, FI: 2.5

Albaladejo-Riad N, Espinosa-Ruiz C, Esteban MA et al. Effect of silk fibroin microparticles on cellular immunity and liver of gilthead seabream (Sparus aurata L.) with and without experimental skin injuries. Journal of Animal Physiology and Animal Nutrition, 2024, 108, 1046-1058, PMID: 38483166, FI: 2.4

Pons-Fuster E, Bernal E*, Guillamon CF, ..., Minguela A. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation. Infectious Diseases, 2024, 56, 818-829, PMID: 38743055, FI: 2.3

Talavera-López J.*, Tudela-González A., Muñoz-Prieto A. Use of a Capsaicin Cough Challenge Test to Compare Four Different Techniques for Nebulization Delivery in Cats Veterinary Sciences, 2024, 11, PMID: null, FI: 2.3

Lopez-Garcia S, Sanchez-Bautista S, Garcia-Bernal D, ..., Rodriguez-Lozano FJ* et al. Premixed calcium silicate-based ceramic sealers promote osteogenic/cementogenic differentiation of human periodontal ligament stem cells: A microscopy study. Microscopy Research and Technique, 2024, 87, 1584-1597, PMID: 38433562, FI: 2.1

Fernández-Sánchez M.C., Ruiz-López F.J., Ros-Lucas J.A. et al. Persons With Chronic Obstructive Pulmonary Disease and High Levels of Activation Improved Their Physical Activity Skills After an Educational Session Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation, 2024, 11, PMID: null, FI: 2.0

Berdardez B, Mangues I, Martinez-Callejo V, Fernandez-Avila JJ et al. Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms French Historical Studies, 2024, , PMID: 38461113, FI: 1.3

Bernardez B, Mangues-Bafalluy I, Callejo VM, Fernandez-Avila JJ et al. Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms. Farmacia Hospitalaria, 2024, 48, 108-115, PMID: 37884399, FI: 1.3

Santarelli G, Sebastian Marcos P, Talavera J et al. Evaluation of a rapid test for point-of-care detection of cardiac troponin I in serum of healthy and diseased dogs and cats. Journal of Veterinary Emergency and Critical Care, 2024, 34, 539-544, PMID: 39558462, FI: 1.2

Zoia A, Morini L, Mazzei A, Talavera Lopez J et al. New strategies to classify canine pleural effusions and the diagnostic value of acute phase proteins, amylase, and adenosine deaminase in pleural exudates. Veterinary Clinical Pathology, 2024, 53, 431-441, PMID: 39434423, FI: 1.1

Ramirez-Roig C, Espuny-Miro A, Olmos-Jimenez R, Diaz-Carrasco MS. Carboplatin dosing in obese patients. Journal of Oncology Pharmacy Practice, 2024, , 10781552241292503, PMID: 39497478, FI: 0.9

Jimenez-Pulido I, Albert-Mari MA, Conde-Estevez D, ..., Diaz-Carrasco MS. GEDEFO-SEFH management of antineoplastic extravasations survey results. Journal of Oncology Pharmacy Practice, 2024, 30, 67-77, PMID: 37032471, FI: 0.9

Sánchez MPM*, Sevilla IN, Sanchis SC. Atypical umbilical endometriosis: Microscopic and immunohistochemical characterization Clinica e Investigacion en Ginecologia y Obstetricia, 2024, 51, PMID: null, FI: 0.1

Sánchez MDM*, Pérez OC, Gómez AM, ..., Díaz AN. Evaluation of hopelessness in patients with endometriosis Clinica e Investigacion en Ginecologia y Obstetricia, 2024, 51, PMID: null, FI: 0.1

AYUDAS CONCEDIDAS EN 2024

TOTAL DE AYUDAS CONCEDIDAS

Nº Ayudas

1.7M €

Financiación

TOTAL DE AYUDAS RECURSOS HUMANOS CONCEDIDAS

Nº Ayudas

0.58M €

Financiación

TOTAL DE AYUDAS PROYECTOS I+D+i CONCEDIDAS

Nº Ayudas Europeas

0.0M €

Financiación Europea

Nº Ayudas Nacionales

0.61M €

Financiación Nacional

Nº Ayudas Regionales

0.28M €

Financiación Regional

TOTAL DE REDES CONCEDIDAS

Nº Ayudas

0.22M €

Financiación

OTRAS AYUDAS COMPETITIVAS CONCEDIDAS (MOVILIDAD, ORGANIZACIÓN DE EVENTOS CIENTÍFICOS, ...)

Nº Ayudas

7.13K €

Financiación

PROYECTOS DE I+D+i Y AYUDAS DE RRHH ACTIVAS EN 2024

TOTAL AYUDAS

RECURSOS HUMANOS

REDES

PROYECTOS INTERNACIONALES

PROYECTOS NACIONALES

PROYECTOS REGIONALES

INICIADA EN 2024

Nº Estudios

Nº Ensayos Clínicos

Nº Producto Sanitario

Nº Estudios Post-Autorización

Nº Otros Estudios

ACTIVOS EN 2024

297

Nº Estudios

197

Nº Ensayos Clínicos

Nº Producto Sanitario

Nº Estudios Post-Autorización

Nº Otros Estudios

FACTURACIÓN EN 2024

1.12M €

Facturado

Nº Tesis (6 con mención internacional)